Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Rituximab Maintenance Therapy for Marginal Zone B-cell Lymphoma (MZL)

This study has been completed.
Information provided by (Responsible Party):
Sung Yong Oh, Dong-A University Hospital Identifier:
First received: September 30, 2010
Last updated: April 7, 2016
Last verified: November 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2015
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)